NCT07239219 The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
| NCT ID | NCT07239219 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Urinary Tract Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-12-31 |
| Primary Completion | 2028-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-12-31 with a primary completion date of 2028-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.
Eligibility Criteria
Inclusion Criteria: 1. Presenting to the urology clinic for catheter removal 2. Must be 18 years or older. 3. The patient must be able to understand and willing to provide informed consent as described in this study protocol. 4. Must be willing to complete a post-catheter removal survey Exclusion Criteria: 1. Allergy or adverse reaction to chlorohexidine gluconate 2. Under the age of 18 3. Refuse to provide informed consent 4. On antibiotic therapy for any indication. 5. Women who are pregnant or breastfeeding 6. Signs of skin or systemic infection 7. Patients undergoing catheter exchange
Frequently Asked Questions
Who can join the NCT07239219 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Urinary Tract Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07239219 currently recruiting?
Yes, NCT07239219 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ohio State University to inquire about joining.
Where is the NCT07239219 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT07239219 clinical trial?
NCT07239219 is sponsored by Ohio State University. The trial plans to enroll 300 participants.